Submitted by Anonymous (not verified) on 27 January 2026 - 16:34
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 14, Status: Authorised